Fulgent Genetics, Inc.

NASDAQ:FLGT

Medical - Diagnostics & Research

Healthcare
$25.13 +1.89%

+$0.33 today

Market cap
$702.11M
Beta
0.92
P/E (TTM)
-7.5
EPS (TTM)
-$2.39
52W Low $13.46High $31.04

Volume 0.39M

Average 0.55M

FLGT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Fulgent Genetics, Inc.NASDAQ: FLGT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 30.2%

Gross margin was 30.2% in Q1 FY2026, down 8.4 pp from a year earlier. On a trailing-twelve-month basis it was 38.7%, down 0.1 pp year over year. Over 3 fiscal years it narrowed by 18.7 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
30.2%-8.9 pp QoQ
Last fiscal yearDec 2025
40.6%+2.7 pp YoY
LTMMar 2026
38.7%-0.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.4 pp——
1 year+2.7 pp——
3 years-18.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
40.6%
Year-over-year change
+2.7pp

Gross Margin vs competitors

How FLGT compares with its peers on the latest reported figures

  • FLGT's LTM Mar 2026 gross margin of 38.7% is the 7th highest of the 8 companies compared; the peer median is 65.3%.
  • Its year-over-year change of -0.1 pp is the 6th highest of 8, against a peer median of +1.0 pp.
  • Over three fiscal years its change of -18.7 pp compares with a peer median of +2.0 pp.
FLGT Competitors Peer median
Gross Margin for FLGT and competitors
Company Period LTM level YoY 3-year change
BLLNBillionToOne, Inc.LTM Jun 202671.3% +10.3 pp—
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
WGSGeneDx Holdings Corp.LTM Jun 202668.2% +1.0 pp+81.1 pp
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
FLGTFulgent Genetics, Inc.LTM Mar 202638.7% -0.1 pp-18.7 pp
PSNLPersonalis, Inc.LTM Mar 202613.7% -19.6 pp—
FRNMFreenome, Inc. Common stock—— ——
Peer median (excluding FLGT) 65.3%+1.0 pp+2.0 pp

Competitors are the stored peer set for FLGT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue992.58M618.97M289.21M283.47M322.67M
Cost of Revenue215.53M252.07M184.76M176.26M191.8M
Gross Profit777.05M366.9M104.46M107.22M130.88M
Gross Margin78.3%59.3%36.1%37.8%40.6%
Research & Development24.22M28.91M41.44M48.82M53.91M
Selling, General & Admin75.17M149.99M130.47M124.35M160.04M
Operating Expenses101.1M188.37M299.99M181.13M221.97M
Depreciation & Amortization11M32.66M26.14M24.93M24.12M
EBITDA692.04M217.7M(147.45M)(26.86M)(45.83M)
EBITDA Margin69.7%35.2%-51.0%-9.5%-14.2%
Operating Income675.95M178.53M(195.53M)(73.92M)(91.1M)
Operating Margin68.1%28.8%-67.6%-26.1%-28.2%
Interest Income1.35M5.62M21.61M31.3M30.92M
Interest Expense01.01M488K170K75K
Other Income / Expenses5.08M5.5M21.44M21.96M21.07M
Income Before Tax681.03M184.03M(174.09M)(51.96M)(70.03M)
Pre-Tax Margin68.6%29.7%-60.2%-18.3%-21.7%
Income Tax Expense174.8M42.1M1.15M(8.14M)(8.39M)
Net Income507.36M143.4M(167.83M)(42.71M)(60.51M)
Net Margin51.1%23.2%-58.0%-15.1%-18.8%
EPS (Basic)17.134.76(5.63)(1.41)(1.97)
EPS (Diluted)16.264.63(5.63)(1.41)(1.97)
Weighted Avg Shares29.41M30.1M29.78M30.24M30.78M
Weighted Avg Shares (Diluted)30.98M30.96M29.78M30.24M30.78M

Fulgent Genetics, Inc.

NASDAQ:FLGT

Intrinsic Alpha fair value

Locked

Current Price

$25.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.